RECALL RECORD — CLASS IIRecall closedF-1045-2019/FDA enforcement

Ctfo Sleep Support Oral Spray with Pure Cbd Hemp Oil Isolate Dietary Supplement, 1oz/30ml

What you need to know

Class II
  • What happened

    Recalling firm's consignee conducted third party micro testing showing microbial contamination in specific lots of the following products: CTFO Sleep Support Oral Spray…

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. Visible or laboratory-detected mold can signal a moisture, temperature or seal failure.

  • Action required

    Stop taking the supplement. Check the lot and UPC codes below, then return it to the retailer or contact the manufacturer about a refund. Seek medical advice if you have concerns about exposure.

Recall closed · classified by the FDADistribution not listedMore supplements

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameNutrafuels, INC.
Recalling firmNutrafuels, INC.Coconut Creek, FL, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • Lot KA022, DOM 11/20/18
Distribution area

US Domestic Consignees only.

United States

Quantity affected676 units
Recall initiationFDA report date: February 27, 2019
FDA recall numberF-1045-2019

Beyond the headline

The recall, in context

Nutrafuels, INC. initiated this supplements recall on January 11, 2019. The FDA enforcement report states: Recalling firm's consignee conducted third party micro testing showing microbial contamination in specific lots of the following products: CTFO Sleep Support Oral Spray (Aspergillus), CTFO Pain Relief Oral Spray (total aerobic bacteria), and CTFO Weight Loss Oral Spray (Enterobacteriaceae). The FDA report lists distribution as: US Domestic Consignees only.

The FDA enforcement report describes the reason as: Recalling firm's consignee conducted third party micro testing showing microbial contamination in specific lots of the following products: CTFO Sleep Support Oral Spray (Aspergillus), CTFO Pain Relief Oral Spray (total aerobic bacteria), and CTFO Weight Loss Oral Spray (Enterobacteriaceae).

Ctfo Sleep Support Oral Spray with Pure Cbd Hemp Oil Isolate Dietary Supplement, 1oz/30ml was made or distributed by Nutrafuels, INC. in Coconut Creek, FL, United States. This page reflects FDA report F-1045-2019, dated February 27, 2019.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, visible or laboratory-detected mold can signal a moisture, temperature or seal failure.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Mold contamination

Symptoms to watch for

Eating a moldy product may cause nausea, vomiting, diarrhea or allergic reactions. Do not intentionally inspect, smell or taste a suspect product.

Higher-risk groups

People with mold allergies, asthma, a weakened immune system, pregnant people and young children should be especially cautious.

What to do now

  1. 1Stop using or eating the affected product and keep it away from children and pets.
  2. 2Match the product against the UPC and lot/date codes on this page, then dispose of it safely or return it to the retailer.
  3. 3If you have already been exposed and develop severe or worsening symptoms, seek medical advice promptly.

Visible mold can indicate a moisture, packaging or temperature failure.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Ctfo Sleep Support Oral Spray with Pure Cbd Hemp Oil Isolate Dietary Supplement, 1oz/30ml recall?

Nutrafuels, INC. recalled Ctfo Sleep Support Oral Spray with Pure Cbd Hemp Oil Isolate Dietary Supplement, 1oz/30ml in an FDA Class II enforcement action reported as F-1045-2019. Recalling firm's consignee conducted third party micro testing showing microbial contamination in specific lots of the following products: CTFO Sleep Support Oral Spray…

What should I do if I bought this product?

Stop taking the supplement. Check the lot and UPC codes below, then return it to the retailer or contact the manufacturer about a refund. Seek medical advice if you have concerns about exposure. Stop using or eating the affected product and keep it away from children and pets. Match the product against the UPC and lot/date codes on this page, then dispose of it safely or return it to the retailer. If you have already been exposed and develop severe or worsening symptoms, seek medical advice promptly.

Is the Nutrafuels, INC. recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-1045-2019. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Nutrafuels, INC.

View brand

Related alerts

Recent Mold recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.